Рыночные новости
Заголовки по акциям и крипте из Alpaca. Храним 7 дней. Всего: 9749.
-
Gallmetzer HealthCare S.p.A. Reports Managers' TransactionGallmetzer HealthCare S.p.A. disclosed a minor share disposal by its majority shareholder, Gallmetzer Holding SRL, in a regulatory filing.
-
Goodtech ASA: Mandatory notification of trade by primary insider (Frode Haugli)Board member Frode Haugli, through his company Edorf Invest AS, purchased 7,000 shares of Goodtech ASA.
-
Goodtech ASA: Mandatory notification of trade by primary insider (Stefano Bardellotto)CBDO Stefano Bardellotto, through his company Icaro AS, purchased 15,000 shares of Goodtech ASA.
-
Hopscotch Launches New Entity 'Hopscotch Public Engagement'Hopscotch Groupe has announced the launch of Hopscotch Public Engagement, a new entity specifically dedicated to supporting European institutions with their communication challenges.
-
Euromax Resources Announces Proposed Private PlacementEuromax Resources Ltd. has announced a non-brokered private placement to raise approximately C$5.69 million in gross proceeds for general working capital.
-
Theraclion Receives Market Authorization for Sonovein in Saudi ArabiaTheraclion has secured regulatory approval to market its Sonovein ultrasound therapy platform in Saudi Arabia.
-
I-Tech: EU vote as expectedRedeye has published a research note regarding the outcome of an EU vote relevant to I-Tech.
-
Nordisk Bergteknik Reports Q3 2026 Interim ResultsNordisk Bergteknik released its interim report for the third quarter of 2026, highlighting flat sales, improved adjusted EBIT margins, and increased nine-month revenue.
-
Novamarine Enters Partnership with EDGE for Unmanned Surface VesselsNovamarine has announced a strategic agreement with the French company EDGE to collaborate on the development of autonomous naval drones.
-
SaltX Technology Receives Holcim Order for ECR Technology DevelopmentSaltX Technology has received an order from Holcim for an expanded development program focused on its Electric Arc Calciner (ECR) technology, including material testing and process optimization.
-
Ezentis Shareholders Approve Capital Increase and Reverse Stock SplitGrupo Ezentis has received shareholder approval for a capital increase via debt-for-equity swap and a subsequent reverse stock split.
-
LumenRadio AB Reports Q3 2026 Interim ResultsLumenRadio AB released its interim report for the third quarter of 2026, highlighting improved gross margins despite a decline in quarterly sales due to weaker demand in the Chinese entertainment-lighting market.
-
AecorBio Appoints Prof. Karl G. Sylvester as Co-Founder and Consulting Chief Medical OfficerHofseth BioCare ASA announced that its US spin-out, AecorBio Inc., has appointed Prof. Karl G. Sylvester, M.D., as Co-Founder and Consulting Chief Medical Officer.
-
Lytix Biopharma's NeoLIPA Treatment Meets Primary Endpoint in Clinical TrialLytix Biopharma announced that its NeoLIPA combination therapy for melanoma has successfully met its primary endpoint in a clinical trial.
-
Director of Casino Neuchâtel SA to DepartPascal Passarelli, the long-standing director of Casino Neuchâtel SA, a subsidiary of the Kursaal Bern Group, has announced his intention to leave the company in the summer of 2027.
-
Biotalys Receives Approval for Large-Scale Commercial Field Trials of EVOCA NG in the NetherlandsBiotalys has been granted approval by the Dutch Board for the Authorisation of Plant Protection Products and Biocides to conduct large-scale demonstration trials of its next-generation biofungicide, EVOCA NG.
-
Rush University System for Health Selects AGFA HealthCare's Enterprise Imaging CloudRush University System for Health has chosen AGFA HealthCare's Enterprise Imaging Cloud to unify its medical imaging strategy across its multi-hospital health system.
-
The Kingfish Company Announces Extension of CEO Vincent Erenst's Tenure and CFO Jean-Charles Valette's Intention to Step DownThe Kingfish Company has extended the contract of CEO Vincent Erenst while announcing that CFO Jean-Charles Valette intends to step down from his position.
-
SynAct Pharma Announces Initiation of Coverage by BioVal BioStock AnalyticsSynAct Pharma has engaged BioVal BioStock Analytics to provide research coverage, with an initial valuation of SEK 2.9 billion for three of its drug assets.
-
Embellence Group Reports Q3 2026 Financial ResultsEmbellence Group AB reported a 3% increase in Q3 sales to SEK 178 million, driven by direct-to-consumer growth, while facing headwinds from retail softness.